Charles Rhyee
Stock Analyst at TD Cowen
(1.23)
# 3,437
Out of 4,734 analysts
50
Total ratings
36.36%
Success rate
-11.04%
Average return
Main Sectors:
Stocks Rated by Charles Rhyee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CAH Cardinal Health | Upgrades: Buy | $130 → $144 | $127.83 | +12.65% | 2 | Jan 8, 2025 | |
| CRL Charles River Laboratories International | Maintains: Hold | $203 → $227 | $169.81 | +33.68% | 5 | Nov 11, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $23 → $25 | $18.70 | +33.69% | 3 | Nov 11, 2024 | |
| TDOC Teladoc Health | Maintains: Hold | $9 → $8 | $9.50 | -15.79% | 6 | Oct 31, 2024 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $369 → $285 | $205.07 | +38.98% | 3 | Oct 25, 2024 | |
| MEDP Medpace Holdings | Maintains: Buy | $413 → $372 | $347.52 | +7.04% | 3 | Oct 23, 2024 | |
| VEEV Veeva Systems | Maintains: Hold | $180 → $192 | $223.04 | -13.92% | 3 | Aug 29, 2024 | |
| GDRX GoodRx Holdings | Maintains: Buy | $14 → $16 | $4.71 | +239.70% | 7 | May 16, 2024 | |
| TALK Talkspace | Maintains: Outperform | $4 → $5 | $3.14 | +59.24% | 2 | May 3, 2023 | |
| AMWL American Well | Downgrades: Market Perform | $100 → $50 | $10.98 | +355.37% | 3 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $251 | $205.69 | +22.03% | 1 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $56 | $4.38 | +1,178.54% | 2 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $18 → $14 | $0.71 | +1,871.83% | 3 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $48 → $50 | $10.17 | +391.64% | 2 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $325 → $361 | $586.08 | -38.40% | 3 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $3,240 | $1.80 | +179,900.00% | 1 | Jul 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $35 | $22.09 | +58.44% | 1 | Feb 13, 2018 |
Cardinal Health
Jan 8, 2025
Upgrades: Buy
Price Target: $130 → $144
Current: $127.83
Upside: +12.65%
Charles River Laboratories International
Nov 11, 2024
Maintains: Hold
Price Target: $203 → $227
Current: $169.81
Upside: +33.68%
Fortrea Holdings
Nov 11, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $18.70
Upside: +33.69%
Teladoc Health
Oct 31, 2024
Maintains: Hold
Price Target: $9 → $8
Current: $9.50
Upside: -15.79%
ICON Public Limited Company
Oct 25, 2024
Maintains: Buy
Price Target: $369 → $285
Current: $205.07
Upside: +38.98%
Medpace Holdings
Oct 23, 2024
Maintains: Buy
Price Target: $413 → $372
Current: $347.52
Upside: +7.04%
Veeva Systems
Aug 29, 2024
Maintains: Hold
Price Target: $180 → $192
Current: $223.04
Upside: -13.92%
GoodRx Holdings
May 16, 2024
Maintains: Buy
Price Target: $14 → $16
Current: $4.71
Upside: +239.70%
Talkspace
May 3, 2023
Maintains: Outperform
Price Target: $4 → $5
Current: $3.14
Upside: +59.24%
American Well
Mar 23, 2023
Downgrades: Market Perform
Price Target: $100 → $50
Current: $10.98
Upside: +355.37%
Dec 6, 2022
Initiates: Outperform
Price Target: $251
Current: $205.69
Upside: +22.03%
Oct 20, 2022
Maintains: Outperform
Price Target: $70 → $56
Current: $4.38
Upside: +1,178.54%
Aug 16, 2022
Maintains: Outperform
Price Target: $18 → $14
Current: $0.71
Upside: +1,871.83%
Jun 21, 2022
Maintains: Outperform
Price Target: $48 → $50
Current: $10.17
Upside: +391.64%
Apr 18, 2022
Maintains: Outperform
Price Target: $325 → $361
Current: $586.08
Upside: -38.40%
Jul 16, 2020
Initiates: Outperform
Price Target: $3,240
Current: $1.80
Upside: +179,900.00%
Feb 13, 2018
Initiates: Market Perform
Price Target: $35
Current: $22.09
Upside: +58.44%